Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting REV-ERBα/BNIP3 axis attenuates pulmonary arterial hypertension by repressing mitophagy in mice.

Nature communications·2026
Same author

Unannotated noncoding transcripts as a source of intratumor heterogeneity in malignant cell states.

Science China. Life sciences·2026
Same author

Circadian rhythms and microbiota: molecular crosstalk and its implications for health and disease.

Biology direct·2026
Same author

Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update.

Nature medicine·2026
Same author

Multi-organ network of cardiometabolic disease-depression multimorbidity revealed by phenotypic and genetic analyses of MR images.

Nature communications·2026
Same author

Short-term exposure to ambient air pollution and onset of severe mental disorders: a case-crossover study in Northwestern China.

BMC public health·2025
Same journal

Lack of Association between the Cytochrome P450 4F2 rs2108622 Genotype and Responses to Valsartan and Amlodipine among a Sample of Jordanian Hypertensive Patients.

Prostaglandins & other lipid mediators·2026
Same journal

A comprehensive review on the mechanistics of free fatty acid-induced insulin resistance and it's therapeutics: Molecular perspectives.

Prostaglandins & other lipid mediators·2026
Same journal

NPY deficiency protects against osteoporosis by altering bone lipid metabolism.

Prostaglandins & other lipid mediators·2026
Same journal

Beyond association: Mediation roles of lipidomics and cytokine in PCOS uncovered by cross-disciplinary genomics.

Prostaglandins & other lipid mediators·2026
Same journal

Aging induces the hepatic CYP4A-20-HETE axis with stage-dependent oxylipin remodeling.

Prostaglandins & other lipid mediators·2026
Same journal

Impact of COX-2 inhibition by DuP-697 on cyclin B1/Cdc2 dynamics in human medullary thyroid carcinoma cells.

Prostaglandins & other lipid mediators·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

Prostanoids and inflammatory pain.

Lihong Chen1, Guangrui Yang, Tilo Grosser

  • 1Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.

Prostaglandins & Other Lipid Mediators
|September 18, 2012
PubMed
Summary
This summary is machine-generated.

Nonsteroidal anti-inflammatory drugs (NSAIDs) manage inflammatory pain but cause side effects. Targeting prostaglandin E2 pathways offers a safer alternative for pain relief by focusing on downstream elements.

More Related Videos

A Modified Inflammatory Pain Model to Study the Analgesic Effect in Mice
06:54

A Modified Inflammatory Pain Model to Study the Analgesic Effect in Mice

Published on: November 15, 2024

Prostaglandin Extraction and Analysis in Caenorhabditis elegans
08:50

Prostaglandin Extraction and Analysis in Caenorhabditis elegans

Published on: June 25, 2013

Related Experiment Videos

Last Updated: May 18, 2026

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

A Modified Inflammatory Pain Model to Study the Analgesic Effect in Mice
06:54

A Modified Inflammatory Pain Model to Study the Analgesic Effect in Mice

Published on: November 15, 2024

Prostaglandin Extraction and Analysis in Caenorhabditis elegans
08:50

Prostaglandin Extraction and Analysis in Caenorhabditis elegans

Published on: June 25, 2013

Area of Science:

  • Biochemistry
  • Pharmacology
  • Pain Research

Background:

  • Prostanoids are key mediators in inflammation and pain signaling.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX) enzymes, reducing prostanoid production for pain management.
  • NSAIDs are associated with significant gastrointestinal and cardiovascular adverse effects.

Purpose of the Study:

  • To review the roles of specific prostanoids in the modulation of inflammatory pain.
  • To explore alternative therapeutic targets beyond COX inhibition for inflammatory pain.
  • To discuss the potential of targeting downstream pathway elements of prostaglandin E2.

Main Methods:

  • Literature review of existing research on prostanoids and inflammatory pain.
  • Analysis of the roles of individual prostanoids in pain pathways.
  • Evaluation of cyclooxygenase (COX) enzyme downstream targets.

Main Results:

  • Prostanoids significantly influence inflammatory pain mechanisms.
  • Cyclooxygenase (COX) inhibitors, while effective, present safety concerns.
  • Prostaglandin E2 (PGE2) pathway elements are identified as promising alternative targets.

Conclusions:

  • Targeting downstream components of prostanoid synthesis, such as prostaglandin E2 synthases and receptors, may offer safer anti-inflammatory and analgesic strategies.
  • Further research into these alternative targets could lead to novel therapeutics with improved safety profiles compared to traditional NSAIDs.
  • Understanding individual prostanoid roles is crucial for developing effective pain management interventions.